Who May Apply for National Registration in Belarus

1. Key takeaways

The eligibility of an applicant (zayavitel) for national registration in Belarus is governed by the registration rules; for foreign manufacturers, the practical route is to submit the application through a local representative in Belarus. GRZAN was unable to obtain the full original text of Article 6 of the former Resolution No. 1269 concerning applicant eligibility, so this series expresses the point that foreign manufacturers must proceed through a local representative as a practical estimate rather than as a legal assertion. This distinction matters for contract design: a company that treats the arrangement as a settled statutory requirement builds its agreements on an assumption it cannot yet verify against the current instrument, while a company that ignores it risks filing an application the receiving authority treats as improperly submitted. The prudent position is therefore twofold: treat the local representative route as the working assumption for planning, and track the text of Resolution No. 211 until the specific provision on applicant eligibility has been located and read in full. Everything else in the project — who signs the submission, who answers technical queries, who bears the duty to report adverse events — hangs on this answer, which is why it belongs at the front of the series.

2. Legal basis

The table should be read as a status snapshot rather than a complete citation set. Resolution No. 211 is the operative instrument for national registration, but its provision on applicant eligibility has not been located in full text, so the fourth column flags that gap explicitly. Resolution No. 1269 is retained in the table only because teams still encounter it in older dossiers and marketing materials, and it must not be cited for anything after 2026-05-01. Ministry of Health Resolution No. 55 governs how the application package is submitted and accepted, which is where the practical question of who may file becomes procedural rather than abstract.

3. Expert insights

Insight one: applicant eligibility and the authorised representative are two distinct layers of the same question. The applicant is the entity standing in the position of filer, responsible for the application documents; the authorised representative is the entrusted party empowered by the foreign manufacturer to handle matters on its behalf. The two may coincide, where the local representative is both empowered and acts as applicant, or may be separated, where the foreign manufacturer remains the applicant and the local representative only handles procedural tasks under mandate. Companies should set out these two layers explicitly in contract design before any document is drafted, because every downstream duty — answering deficiency letters, confirming changes, maintaining the certificate — attaches to whoever occupies each layer, and ambiguity at this stage resurfaces later as disputes over responsibility.

Insight two: the eligibility provision of the former rules can no longer be cited. No. 1269 lapsed as of 2026-05-01, and its Article 6, as amended by No. 134, which had defined the scope of applicants, withdrew together with the instrument. The current basis is Resolution No. 211. GRZAN has not obtained the original text of the specific provision of No. 211 on applicant eligibility, so this series deliberately refrains from item-by-item listing of who may apply. Teams that continue to quote Article 6 of No. 1269 in dossiers or internal memoranda create a documentation defect that a careful reviewer will catch, and the correction costs far more than rewriting the citation now.

Insight three: different routes impose different applicant requirements. The national route and the Union route diverge on who may stand as applicant. Under the Union route, a manufacturer established outside the Union is expressly required to designate an authorised representative established in a Union member state. When planning both tracks in parallel, companies should confirm the applicant arrangement separately for each route instead of assuming that one structure satisfies both. A structure that works for the national track may fail the Union track at validation, and the reverse is equally true, so the confirmation is a routing decision, not a formality.

Insight four: the identity of the applicant determines where subsequent obligations land. The information printed on the registration certificate, the reporting of adverse events after the product reaches the market, and the party entitled to file change notifications all track back to the applicant. Choosing who acts as applicant is therefore not a question of filing convenience but a question of long-term obligation allocation. A manufacturer that lets a distributor stand as applicant for convenience may find that certificate amendments, post-market reports and register updates all run through an entity it does not control, which becomes a serious dependency when commercial relationships change.

4. Practical recommendations

The recommendations below convert the analysis into contract language and filing practice.

1. Write both layers of the relationship into the contract. State clearly who is the entity responsible for the application documents and who is the entrusted party authorised to handle matters on the manufacturer’s behalf, so that the applicant role and the representative role never blur during the project.
2. Confirm eligibility solely on the basis of No. 211. Do not cite Article 6 of the lapsed No. 1269 anywhere in the dossier, in correspondence or in internal memoranda, and record in the project file that the current citation has been checked against the operative instrument.
3. Confirm the applicant arrangement separately for each track. The national route and the Union route impose different requirements, so dual-track projects should never reuse a single arrangement across both without verifying it against each route’s rules.
4. Write the attribution of subsequent obligations into the agreement. Adverse event reporting, change filings and certificate maintenance should each name the responsible party and the party bearing the associated costs, so that obligations follow the applicant structure rather than commercial habit.

5. Verification checklist

• □ The two-layer relationship between applicant and entrusted agent has been distinguished in the contract
• □ Applicant eligibility has been confirmed under No. 211, without citing No. 1269
• □ Applicant arrangements for both routes have been confirmed separately for dual-track projects
• □ Attribution of subsequent obligations (reporting, changes, maintenance) has been written into the agreement
• □ It has been recorded that the specific provision number on applicant eligibility in No. 211 was not obtained

Regulatory information verified as of 30 October 2026.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities on three areas. First, distinguishing between the applicability conditions and the remaining time windows of the two channels, the Union-wide registration and the national registration of each member state — the national registration procedure of Belarus has been fully re-routed by the Council of Ministers Resolution No. 211 of 28 April 2026 (state register number 6-1/55925, effective 2026-05-01), which compresses the total timeframe for preliminary technical work to 90 calendar days, keeps the list of such work closed, and prohibits the implementing organisation from expanding it, while the window for submitting applications under the national procedure takes 2027-12-31 as its key milestone, so route selection must be decided in step with the time window. Second, local authorised representative services: GRZAN can act as the statutory representative of a manufacturer in Belarus, undertaking registration submission, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison mechanisms after the Council of Ministers Resolution No. 378 of 27 July 2026 (effective 2026-07-30) transferred adverse event functions to the state agency State Pharmaceutical Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and organises technical documentation according to the target route — for the national route, per the annexes to Ministry of Health Resolution No. 55; for the Union route, per EEC Council Decision No. 46.

For business enquiries: info@grzanglobal.com